Alector (ALEC) Total Current Liabilities (2018 - 2026)
Alector (ALEC) posted quarterly Total Current Liabilities of $41.0 million for Q1 2026, down 62.68% year-over-year from $109.8 million in Q1 2025, and down 41.06% quarter-over-quarter from $69.5 million in Q4 2025.
Alector (ALEC) Total Current Liabilities (2018 - 2026) Analysis & Trends
Alector (ALEC) has reported Total Current Liabilities for 9 consecutive years, with $41.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Total Current Liabilities fell 62.68% year-over-year to $41.0 million; the TTM figure through Mar 2026 stood at $41.0 million (down 62.68% YoY), while the FY2025 annual figure was $69.5 million, down 44.42% from the prior year.
- Total Current Liabilities eased to $41.0 million in Q1 2026 per ALEC's latest filing, from $69.5 million in the prior quarter.
- Across five years, Total Current Liabilities topped out at $177.9 million in Q4 2023 and bottomed at $41.0 million in Q1 2026.
- Historically, Total Current Liabilities has averaged $122.2 million across 5 years, with a median of $132.3 million in 2023.
- Annual changes were most pronounced in 2022 — Total Current Liabilities surged 123.03% — and 2026, when it sank 62.68%.
- Alector's Total Current Liabilities stood at $93.8 million in 2022, then jumped by 89.69% to $177.9 million in 2023, then slipped by 29.72% to $125.1 million in 2024, then plunged by 44.42% to $69.5 million in 2025, then slumped by 41.06% to $41.0 million in 2026.
- Business Quant data shows ALEC's Total Current Liabilities at $41.0 million in Q1 2026, $69.5 million in Q4 2025, and $80.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 3.94 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 5.53 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.58 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 354.06 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 2.12 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 4.22 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 630.93 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.51 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 438.74 Mn |
| 10 | Alector | 218.85 Mn | 46.05 Mn | - | 34.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 34.24 Mn |
| Mar 31, 2026 | 40.97 Mn |
| Dec 31, 2025 | 69.50 Mn |
| Sep 30, 2025 | 79.96 Mn |
| Jun 30, 2025 | 84.35 Mn |
| Mar 31, 2025 | 109.77 Mn |
| Dec 31, 2024 | 125.06 Mn |
| Sep 30, 2024 | 142.53 Mn |
| Jun 30, 2024 | 147.68 Mn |
| Mar 31, 2024 | 164.92 Mn |
| Dec 31, 2023 | 177.95 Mn |
| Sep 30, 2023 | 155.40 Mn |
| Jun 30, 2023 | 132.27 Mn |
| Mar 31, 2023 | 99.30 Mn |
| Dec 31, 2022 | 93.81 Mn |
| Sep 30, 2022 | 160.89 Mn |
| Jun 30, 2022 | 149.41 Mn |
| Mar 31, 2022 | 142.88 Mn |
| Dec 31, 2021 | 139.56 Mn |
| Sep 30, 2021 | 132.82 Mn |